Theravance Biopharma | Investor Conference Presentation Deck | 32 slides

Theravance Biopharma · 2023-04
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

32
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
summarize
Open slide detailBeat · Key MessagesLoop · Quick Win Big Bet
04
The slide uses a three-column layout to categorize targets by product and financial performance.summarize
Open slide detailBeat · Key MessagesLoop · Quick Win Big Bet
05
Slide 5 of a corporate presentation.front_matter
06
The slide uses two bar charts to demonstrate growth trends in both financial and operational metrics.analyze_data
Open slide detailBeat · KPI Overview
07
The slide uses a line chart for hospital share and a bar-line combo chart for community share to illustrate market penetration.analyze_data
Open slide detailBeat · KPI Overview
08
The slide uses a timeline-based study design diagram.present_framework
09
establish_context
Open slide detailBeat · ProblemLoop · Cost Of Inaction
10
The slide uses a funnel-like logic to arrive at the addressable population, followed by a competitive comparison table.size_opportunity
Open slide detailBeat · ProblemLoop · Cost Of Inaction
11
Includes a forest plot showing LS Mean (95% CI) for various OHQ questionnaire scores.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
12
The slide outlines a randomized withdrawal study design for a clinical trial.present_framework
13
The slide features a photo of an elderly couple on a bridge, the study logo, and the company logo.other
14
transition
15
summarize
16
The chart shows a significant reduction in operating expenses from 2020 to 2023 guidance.analyze_data
17
The table displays specific financial projections for milestones and royalties between 2023 and 2026.analyze_data
18
Uses a timeline-like arrow to represent progression of value drivers.summarize
20
Includes a footnote defining OATP.other
21
Includes footnote regarding market research methodology and definitions.establish_context
23
introduce_nominees
24
introduce_nominees
25
The slide uses a three-column layout to categorize achievements into product, clinical, and financial pillars.summarize
26
Includes abbreviations for COPD, nOH, and PTE in the footer.analyze_data
27
The funnel visualizes the drop-off from total diagnosed COPD patients to those currently on YUPELRI.size_opportunity
28
The slide serves as a reference or bibliography page for clinical study presentations.other
29
The slide uses a before-after framework to justify a strategic pivot in clinical trial focus.present_solution
30
Includes a detailed table for Trelegy Ellipta milestones and royalty projections.analyze_data
31
Includes specific notes on cash usage and share repurchases.summarize
Open slide detailBeat · Financials
32
Includes cash position note and footnotes regarding share-based compensation.analyze_data
Open slide detailBeat · Financials